ViaCyte, Inc. today announced 165 new patents were issued in 2018. These issued patents provide protection to the Company’s core technologies in the United States, European Union, and other jurisdictions around the world and further reinforce ViaCyte https://www.oaoa.com/news/business/article_eaca54a6-a468-58f0-a2b5-2f6de1b25284.html

Zealand Pharma A/S, a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced the completion of a USD 5 million strategic equity investment in Beta Bionics, a medical technology com https://globenewswire.com/news-release/2019/01/04/1680502/0/en/Zealand-Pharma-completes-equity-investment-in-strategic-partner-Beta-Bionics.html

From smart insulin pen caps to artificial intelligence systems for seniors, Novo Nordisk capped its first innovation challenge last month with five tech-plus-diabetes idea winners. The pharma awarded each winning team a cash prize of $25,000 and 12 weeks https://www.fiercepharma.com/marketing/novo-nordisk-s-first-innovation-challenge-winners-for-diabetes-solutions-head-to-lab

In a first of its kind collaborative initiative in India between a pharmaceutical and medical device company, Eris Lifesciences, one of the leading players in the chronic drugs segment and India Medtronic Pvt. Ltd, a wholly owned subsidiary of Medtronic https://www.biospectrumindia.com/news/43/12404/diabetes-major-eris-lifesciences-joins-hands-with-medtronic-for-diabetes-monitoring-initiative.html